Original ArticlesStage IIIA and IIIB Non-Small Cell Lung Cancer: Results of Chemotherapy Combined With Radiation Therapy and Analysis of Prognostic Factors
REFERENCES (34)
- et al.
Final results of phase III trial in regionally advanced unresectable non small cell lung cancer
Chest
(2000) - et al.
Current standards and ongoing controversies in the management of locally advanced non small cell lung cancer
Semin Oncol
(2005) - et al.
Clinical DVH analysis for pneumonitis after 3D treatment NSCLC
Int J Radiat Oncol Biol Phys
(1999) - et al.
Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy
Int J Radiat Oncol Biol Phys
(2001) - et al.
Can elective nodal irradiation be omitted in stage III non-small cell lung cancer? An analysis of recurrences in a phase II study of induction chemotherapy and “involved-field” radiotherapy
Int J Radiat Oncol Biol Phys
(2002) - et al.
Impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data
Lung Cancer
(2003) - et al.
Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non small cell lung cancer: a randomised trial
Lancet
(1997) - et al.
A phase III trial comparing chemotherapy plus either once a day radiotherapy or twice a day radiotherapy in stage III non small cell lung cancer
Int J Radiat Oncol Biol Phys
(2002) - et al.
Combined modality trials of the cancer and leukemia group B in stage III non small cell lung cancer: analysis of factors influencing survival and toxicity
Ann Oncol
(2004) - et al.
Complete response following preoperative chemotherapy for resectable non small cell lung cancer
Chest
(2005)
Innovations in the radiotherapy of non small cell lung cancer
J Thorac Oncol
(2006)
EORTC-Lung Cancer Group. A randomized trial of radical surgery (RS) versus thoracic radiotherapy (TRT) in patients with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941)
J Clin Oncol
(2005)
North American Lung Cancer Intergroup. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): outcomes update of North American Intergroup 0139 (RTOG 9309)
J Clin Oncol
(2005)
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer
N Engl J Med
(1990)
Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non small cell lung cancer: first analysis of a randomized trial in 353 patients
J Natl Cancer Inst
(1991)
Mitomycin, ifosfamide and cisplatin in unresectable non-small cell lung cancer: effects on survival and quality of life
J Clin Oncol
(1999)
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non small cell lung cancer
J Clin Oncol
(1999)
Cited by (13)
Author's reply
2009, Medicina ClinicaImpact of hemoglobin level on lung cancer survival
2008, Medicina ClinicaDrug-Induced Peripheral Neuropathy: Diagnosis and Management
2022, Current Cancer Drug TargetsDelay of the blink reflex in patients receiving platinum-analogue chemotherapy
2016, Annals of Rehabilitation Medicine
Copyright © 2007 Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Published by Ediciones Doyma S.L. All rights reserved All rights reserved.